Elevated DSG3 Expression Is Correlated With Lung Cancer Progression and Poor Prognosis

Desmoglein 3 (DSG3) is a member of the 7 transmembrane desmosomal cadherins and has been linked to pan-cancer onset and progression. However, its potential association with lung cancer remains unclear. DSG3 expression in lung cancer was evaluated in GEO and TCGA data. Furthermore, bioinformatics analysis was carried out to evaluate the association between immune infiltration and DSG3 expression, together with the clinical significance of DSG3 in lung cancer. GO, KEGG and GSEA enrichment analyses were conducted to dissect downstream signaling pathways associated with DSG3 dysregulation. In vitro functional experiments including CCK-8, colony formation, Transwell migration/invasion and western blot assays were carried out in A549 and H1299 cells with stable DSG3 knockdown to verify its oncogenic function and regulatory role in epithelial-mesenchymal transition (EMT). The data revealed that DSG3 was substantially upregulated in lung cancer and was linked with poorer clinicopathological characteristics and patients' prognosis. Moreover, DSG3 expression was markedly linked with immune cell infiltration in lung cancer. GSEA results further identified significant enrichment of keratinization, cornified envelope formation, matrisome remodeling, developmental biology and post-translational modification pathways in DSG3-high lung cancer samples. Cellular functional assays demonstrated that DSG3 silencing markedly suppressed the proliferation, migration and invasion of cells. Mechanistically, DSG3 knockdown upregulated epithelial marker E-cadherin while downregulating mesenchymal markers N-cadherin, Vimentin and EMT transcription factor Snail. This study showed that elevated DSG3 expression was linked with lung cancer progression and poor prognosis, while DSG3 downregulation inhibited lung cancer cells' migration, proliferation, and invasion by modulating EMT, highlighting DSG3's potential as a therapeutic, diagnostic, and prognostic target for lung cancer.

Authors

Institutions

Publication Details

Journal
Molecular Carcinogenesis
Published
2026-11-17
DOI
https://doi.org/10.1002/mc.70205
Primary Topic
Lung Cancer Research Studies
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Elevated DSG3 Expression Is Correlated With Lung Cancer Progression and Poor Prognosis

Xiaowei Wang, Hongyuan Chen, Jiang Hong, Jian Yang
Molecular Carcinogenesis
Lung Cancer Research Studies
article

Elevated DSG3 Expression Is Correlated With Lung Cancer Progression and Poor Prognosis

Xiaowei Wang, Hongyuan Chen, Jiang Hong, Jian Yang
article en

Abstract

Desmoglein 3 (DSG3) is a member of the 7 transmembrane desmosomal cadherins and has been linked to pan-cancer onset and progression. However, its potential association with lung cancer remains unclear. DSG3 expression in lung cancer was evaluated in GEO and TCGA data. Furthermore, bioinformatics analysis was carried out to evaluate the association between immune infiltration and DSG3 expression, together with the clinical significance of DSG3 in lung cancer. GO, KEGG and GSEA enrichment analyses were conducted to dissect downstream signaling pathways associated with DSG3 dysregulation. In vitro functional experiments including CCK-8, colony formation, Transwell migration/invasion and western blot assays were carried out in A549 and H1299 cells with stable DSG3 knockdown to verify its oncogenic function and regulatory role in epithelial-mesenchymal transition (EMT). The data revealed that DSG3 was substantially upregulated in lung cancer and was linked with poorer clinicopathological characteristics and patients' prognosis. Moreover, DSG3 expression was markedly linked with immune cell infiltration in lung cancer. GSEA results further identified significant enrichment of keratinization, cornified envelope formation, matrisome remodeling, developmental biology and post-translational modification pathways in DSG3-high lung cancer samples. Cellular functional assays demonstrated that DSG3 silencing markedly suppressed the proliferation, migration and invasion of cells. Mechanistically, DSG3 knockdown upregulated epithelial marker E-cadherin while downregulating mesenchymal markers N-cadherin, Vimentin and EMT transcription factor Snail. This study showed that elevated DSG3 expression was linked with lung cancer progression and poor prognosis, while DSG3 downregulation inhibited lung cancer cells' migration, proliferation, and invasion by modulating EMT, highlighting DSG3's potential as a therapeutic, diagnostic, and prognostic target for lung cancer.

Molecular Carcinogenesis
Second Military Medical University (CN), Changhai Hospital (CN)
Good health and well-being
Lung Cancer Research Studies
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon